Brief: HOOKIPA Pharma Q4 Net Income USD -24.817 Million
22/03/2024 11:01
Mar 22 (Reuters) - HOOKIPA Pharma Q4 operating income USD -30.894 million. * Q4 revenue USD 7.407 million * Q4 basic EPS USD -0.22 * Q4 operating expenses USD -38.301 million
Recent news on Hookipa Pharma
See all newsBrief: Hookipa Pharma Announces Sale Of Oncology Assets To Neotrail Therapeutics
Brief: Hookipa Pharma Announces Intention To Voluntarily Delist And Deregister Its Common Stock
Hookipa Pharma Inc Expected To Post A Loss Of $1.04 A Share: Earnings Preview
Brief: Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)